NASDAQ:MGLNMagellan Health Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Magellan Health Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $71.17 +0.78 (+1.11 %) (As of 05/26/2020 04:00 PM ET) Add Compare Share Today's Range$69.09Now: $71.17▼$71.5050-Day Range$41.73MA: $59.78▼$71.1752-Week Range$30.60Now: $71.17▼$81.04Volume172,300 shsAverage Volume271,781 shsMarket Capitalization$1.78 billionP/E Ratio23.80Dividend YieldN/ABeta1.14 ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Magellan Health, Inc. provides healthcare management services in the United States. The company operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans (EAP); and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine. It also contracts with state Medicaid agencies, and the centers for Medicare and Medicaid services to manage care for beneficiaries under Medicaid and Medicare programs, such as healthcare and long-term support services through its network of medical and behavioral health professionals, clinics, hospitals, nursing facilities, home care agencies, and ancillary service providers. The Pharmacy Management segment comprises products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. It offers pharmacy benefit management services, such as pharmaceutical dispensing services; pharmacy benefit administration for state Medicaid and other government sponsored programs; clinical and formulary management programs; medical pharmacy management programs; and programs for the integrated management of specialty drugs that treat complex conditions. The company provides services to health plans and other managed care organizations, employers, labor unions, various military and governmental agencies, and third party administrators. Magellan Health, Inc. was founded in 1969 and is headquartered in Scottsdale, Arizona.Read More Beat the Market (BTM) Rank™ 1.0 Analyst's Opinion Consensus RatingMagellan Health has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $67.00, Magellan Health has a potential downside of 5.9% from its current price of $71.17.Amount of Analyst CoverageMagellan Health has received no research coverage in the past 90 days. Previous Next 2.4 Community Rank Outperform VotesMagellan Health has received 358 “outperform” votes. (Add your “outperform” vote.)Underperform VotesMagellan Health has received 382 “underperform” votes. (Add your “underperform” vote.)Community SentimentMagellan Health has received 51.62% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Magellan Health and other stocks. Vote “Outperform” if you believe MGLN will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MGLN will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldMagellan Health does not currently pay a dividend.Dividend GrowthMagellan Health does not have a long track record of dividend growth. Previous Next 4.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Magellan Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought $304,335.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 14.10% of the stock of Magellan Health is held by insiders.Percentage Held by Institutions99.32% of the stock of Magellan Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Magellan Health are expected to grow by 30.26% in the coming year, from $3.04 to $3.96 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Magellan Health is 23.80, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 12.66.Price to Earnings Ratio vs. SectorThe P/E ratio of Magellan Health is 23.80, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 15.35.Price to Earnings Growth RatioMagellan Health has a PEG Ratio of 1.29. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioMagellan Health has a P/B Ratio of 1.24. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 1.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 4.0Valuation: 1.3 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.73 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Hospitals Sub-IndustryManaged Health Care SectorMedical Current SymbolNASDAQ:MGLN Previous Symbol CUSIP55907920 CIK19411 Webwww.magellanhealth.com Phone602-572-6050Debt Debt-to-Equity Ratio0.45 Current Ratio1.75 Quick Ratio1.71Price-To-Earnings Trailing P/E Ratio23.80 Forward P/E Ratio23.41 P/E Growth1.29 Sales & Book Value Annual Sales$7.16 billion Price / Sales0.25 Cash Flow$9.10 per share Price / Cash Flow7.82 Book Value$57.33 per share Price / Book1.24Profitability EPS (Most Recent Fiscal Year)$3.73 Net Income$55.90 million Net Margins1.02% Return on Equity8.02% Return on Assets3.53%Miscellaneous Employees10,100 Outstanding Shares24,970,000Market Cap$1.78 billion Next Earnings Date8/4/2020 (Estimated) OptionableOptionable NASDAQ:MGLN Rates by TradingView Receive MGLN News and Ratings via Email Sign-up to receive the latest news and ratings for MGLN and its competitors with MarketBeat's FREE daily newsletter. Magellan Health (NASDAQ:MGLN) Frequently Asked Questions How has Magellan Health's stock been impacted by COVID-19 (Coronavirus)? Magellan Health's stock was trading at $53.88 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, MGLN stock has increased by 32.1% and is now trading at $71.17. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Magellan Health? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Magellan Health in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Magellan Health. When is Magellan Health's next earnings date? Magellan Health is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Magellan Health. How were Magellan Health's earnings last quarter? Magellan Health Inc (NASDAQ:MGLN) posted its quarterly earnings data on Monday, May, 11th. The company reported $1.15 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.72 by $0.43. The company had revenue of $1.79 billion for the quarter, compared to analysts' expectations of $1.78 billion. Magellan Health had a return on equity of 8.02% and a net margin of 1.02%. The firm's quarterly revenue was up 3.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.40 EPS. View Magellan Health's earnings history. What guidance has Magellan Health issued on next quarter's earnings? Magellan Health updated its FY20 earnings guidance on Friday, February, 28th. The company provided EPS guidance of $3.43-4.14 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.70. The company issued revenue guidance of $7.0-7.4 billion, compared to the consensus revenue estimate of $7.44 billion. What price target have analysts set for MGLN? 1 brokers have issued 12-month price objectives for Magellan Health's shares. Their forecasts range from $67.00 to $67.00. On average, they anticipate Magellan Health's stock price to reach $67.00 in the next twelve months. This suggests that the stock has a possible downside of 5.9%. View analysts' price targets for Magellan Health. Has Magellan Health been receiving favorable news coverage? Press coverage about MGLN stock has been trending extremely positive on Wednesday, InfoTrie reports. The research group ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Magellan Health earned a daily sentiment score of 5.0 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news aboutMagellan Health. Are investors shorting Magellan Health? Magellan Health saw a increase in short interest in April. As of April 30th, there was short interest totaling 804,600 shares, an increase of 13.6% from the April 15th total of 708,400 shares. Based on an average daily trading volume, of 191,800 shares, the days-to-cover ratio is currently 4.2 days. Approximately 3.3% of the company's shares are short sold. View Magellan Health's Current Options Chain. Who are some of Magellan Health's key competitors? Some companies that are related to Magellan Health include UnitedHealth Group (UNH), Anthem (ANTM), Cigna (CI), Humana (HUM), Centene (CNC), Molina Healthcare (MOH) and Triple-S Management (GTS). View all competitors. What other stocks do shareholders of Magellan Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Magellan Health investors own include Energy Transfer LP Unit (ET), General Motors (GM), Netflix (NFLX), Boeing (BA), Ford Motor (F), NVIDIA (NVDA), UnitedHealth Group (UNH), Broadcom (AVGO), ConocoPhillips (COP) and Enbridge (ENB). Who are Magellan Health's key executives? Magellan Health's management team includes the following people: Mr. Barry Morgan Smith, Chairman, CEO & CEO of Magellan Healthcare (Age 65)Mr. Jonathan Neal Rubin, Chief Financial Officer (Age 55)Mr. Daniel Norman Gregoire, Gen. Counsel & Sec. (Age 63)Mr. Mostafa M. Kamal, Chief Exec. Officer of Magellan Rx Management (Age 38)Ms. Renie Shapiro Silver, SVP - Corp. Fin. What is Magellan Health's stock symbol? Magellan Health trades on the NASDAQ under the ticker symbol "MGLN." Who are Magellan Health's major shareholders? Magellan Health's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (13.77%), Victory Capital Management Inc. (5.50%), Victory Capital Management Inc. (5.50%), JPMorgan Chase & Co. (4.25%), State Street Corp (3.74%) and Geode Capital Management LLC (1.38%). Company insiders that own Magellan Health stock include Barry M Smith, James E Murray and Jeffrey N West. View institutional ownership trends for Magellan Health. Which major investors are selling Magellan Health stock? MGLN stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Morgan Stanley, BlackRock Inc., Two Sigma Advisers LP, Alberta Investment Management Corp, Bank of New York Mellon Corp, Citigroup Inc., and Invesco Ltd.. View insider buying and selling activity for Magellan Health. Which major investors are buying Magellan Health stock? MGLN stock was purchased by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Victory Capital Management Inc., Victory Capital Management Inc., Nuveen Asset Management LLC, Matarin Capital Management LLC, State Street Corp, Russell Investments Group Ltd., and AQR Capital Management LLC. View insider buying and selling activity for Magellan Health. How do I buy shares of Magellan Health? Shares of MGLN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Magellan Health's stock price today? One share of MGLN stock can currently be purchased for approximately $71.17. How big of a company is Magellan Health? Magellan Health has a market capitalization of $1.78 billion and generates $7.16 billion in revenue each year. The company earns $55.90 million in net income (profit) each year or $3.73 on an earnings per share basis. Magellan Health employs 10,100 workers across the globe. What is Magellan Health's official website? The official website for Magellan Health is www.magellanhealth.com. How can I contact Magellan Health? Magellan Health's mailing address is 4800 SCOTTSDALE ROAD, SCOTTSDALE AZ, 85251. The company can be reached via phone at 602-572-6050 or via email at [email protected] This page was last updated on 5/27/2020 by MarketBeat.com Staff
